Zeta Global (ZETA) presents a high-conviction "universally cheap" AI opportunity, trading at a rare 0.14 valuation multiple despite a dominant proprietary database and strong Rule of 40 performance. Investors should look to Hims & Hers Health (HIMS) as a discounted growth play in personalized medicine, specifically for its expansion into GLP-1 weight-loss drugs and a valuation currently under 0.1 EV/GP/RG. SoFi Technologies (SOFI) is a primary recovery candidate to accumulate now, as it is positioned to surge once interest rates begin to decline. Within the blockchain sector, Solana (SOL) is the preferred network for speed and adoption, with Forward Industries (FORD) serving as a strategic proxy for traditional brokerage accounts. While many AI leaders are currently overheated, NVIDIA (NVDA) remains the only major chip play with a fair valuation relative to its growth, whereas Tesla (TSLA) offers long-term value in the emerging physical AI space.

Zeta Global (ZETA)

• Described as the "Palantir of Marketing," Zeta operates a platform that sits on top of various marketing tools to coordinate campaigns.
• The company recently introduced Athena, an AI agent designed to act as a "marketing chief" for enterprises.
• Valuation: Currently trading at an EV/GP/RG (Enterprise Value to Gross Profit divided by Revenue Growth) of 0.14, which the analyst considers "universally cheap" (anything under 0.2 is rare).
• Performance: Achieves a Rule of 40 score of 57. Despite growing sales by 50% in Q1, the stock has remained stagnant while the broader market rose.
• Moat: Maintains a proprietary database tracking 245 million people in America longitudinally in a compliant manner, creating a network effect that competitors like The Trade Desk may lack.

Takeaways

• Investment Opportunity: Viewed as an undervalued AI play that the market is currently ignoring.
• Long-term Outlook: Management has provided guidance through 2028 implying sustained high growth; the analyst sees a 5-to-10-year horizon for their AI agent integration.

SoFi Technologies (SOFI)

• The analyst views SoFi as a "machine" consistently firing on all cylinders with the goal of becoming a Top 10 financial institution.
• Price Action: The stock was recently near $25 but has been roughly halved in the last six months; it is currently trading significantly cheaper than its peer Nubank (NU).
• Macro Sensitivity: The stock is heavily suppressed by high interest rates. Management recently adjusted guidance to account for fewer expected rate cuts.

Takeaways

• Bullish Catalyst: As soon as interest rates drop, SoFi is expected to be a primary beneficiary as demand for lending increases.
• Sentiment: The analyst believes the market's negative reaction to recent earnings is irrational given the underlying growth numbers.

Hims & Hers Health (HIMS)

• Described as an "AI-enabled doctor" and pharmacy, Hims is currently trading around $26, down 50% from its highs of the previous year.
• Business Model: Uses MedMatch (AI) to match patients with drugs and focuses on "one-to-one" customized compounding (e.g., personalized dosages for weight loss or ED).
• Competitive Edge: By not taking insurance, they offer transparent pricing (often cheaper than standard co-pays) and faster service (providers available within 24 hours).
• Recent Developments: Launched in Canada and secured partnerships with Novo Nordisk and Eli Lilly to sell official GLP-1 drugs (Semaglutide/Tirzepatide).

Takeaways

• Valuation: Trading at an EV/GP/RG under 0.1, which the analyst considers "way too cheap" for a company achieving the Rule of 40.
• Growth: The acquisition of Eucalyptus and international expansion provide further tailwinds.

Blockchain & Cryptocurrency Sector

• The analyst believes capital is "chasing the AI trade" and prematurely exiting the blockchain sector, leaving it undervalued.
• Bitcoin (BTC): Mentioned as a core asset; the analyst praised Michael Saylor (MicroStrategy) for his recent earnings call, despite the market's negative reaction.
• Solana (SOL): Viewed as a "staking network" or decentralized computer. The analyst prefers it over Ethereum (ETH), which he considers too slow and lagging in stablecoin adoption.
• Hyperliquid: Highlighted as an innovative decentralized exchange competing with the NYSE through "Perpetual Preferred" assets.

Takeaways

• Actionable Proxies: For those using traditional brokerage accounts (TradFi), the analyst mentions Forward Industries (FORD) as a preferred Solana proxy and Perr (via a NASDAQ-listed vehicle) for Hyperliquid exposure.
• Sector Sentiment: Bullish on decentralized applications (social media, shopping, chat) being built on these networks over the next few years.

AI Sector Comparisons (Quick Hits)

• NVIDIA (NVDA): The only major AI stock the analyst believes has not run up too much relative to its value.
• Tesla (TSLA): Viewed as "cheap" in the context of Physical AI, though this is a multi-year story.
• Meta (META): Seen as reasonably priced and successfully investing in AI and hardware (Meta glasses).
• Overvalued/Avoid: The analyst is bearish on AMD, Micron (MU), Microsoft (MSFT), and Google (GOOGL) at current levels, suggesting they are "overheated" and due for a mean reversion.